--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2023/Q30.000 / 0.000--
--2023/Q20.000 / 0.000--
--2022/Q30.000 / 0.000--
Vale SA
VALE
D.R. Horton
DHI
Taylor Morrison Home
TMHC
Petroleo Brasileiro SA Petrobras
PBR
Lennar Corp
LEN
US Stock MarketDetailed Quotes
CNSP CNS Pharmaceuticals
- 3.4311
- +0.3711+12.13%
Trading Mar 18 15:39 ET
5.14MMarket Cap0.00P/E (TTM)
3.5000High3.0600Low130.98KVolume3.2000Open3.0600Pre Close426.96KTurnover8.87%Turnover Ratio0.00P/E (Static)1.50MShares975.000052wk High1.53P/B5.07MFloat Cap2.000052wk Low--Dividend TTM1.48MShs Float426742.5000Historical High--Div YieldTTM14.38%Amplitude2.0000Historical Low3.2590Avg Price1Lot Size
CNS Pharmaceuticals Key Stats
CNS Pharmaceuticals Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
CNS Pharmaceuticals Earnings Reports
Read more
Trending Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.